Article info
PDFBasic and translational research
The novel small molecule drug Rabeximod is effective in reducing disease severity of mouse models of autoimmune disorders
- R Holmdahl, Medical Inflammation Research, I11 BMC, Lund University, S-221 84 Lund, Sweden; rikard.holmdahl{at}med.lu.se
Citation
The novel small molecule drug Rabeximod is effective in reducing disease severity of mouse models of autoimmune disorders
Publication history
- Accepted March 8, 2008
- First published March 17, 2008.
Online issue publication
November 02, 2019
Article Versions
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group and European League Against Rheumatism